News and Stories About NCCN

Family members discuss genetic testing and family history of pancreatic and other cancer

Do You Know Your Risk?

Oct 26, 2020

If you have a first-degree relative (parent, child or sibling) who was diagnosed with pancreatic cancer, you may have an […]
READ MORE

Doctors read updated guidelines for treating pancreatic cancer patients

Guidelines Advise Germline and Somatic Testing

Apr 12, 2019

Editor’s note: The National Comprehensive Cancer Network (NCCN), which sets guidelines for the treatment and management of pancreatic adenocarcinoma (the […]
READ MORE

Pancreatic cancer healthcare providers and experts convene to discuss changes in best practices

New Guidelines Feature Pancreatic Cancer Treatment Advances

Mar 14, 2019

Editor’s note: The National Comprehensive Cancer Network (NCCN) released updated guidelines for the treatment and management of pancreatic adenocarcinoma, the […]
READ MORE

PanCAN executive joins fellow NCCN panelists for a discussion on equal care for cancer patients

PanCAN Joins National Summit on Patient Advocacy

Dec 10, 2018

All cancer patients deserve the best care available, but not all can receive it. For some, the problem is financial. […]
READ MORE

Doctor follows new guidelines to discuss genetic testing with all pancreatic cancer patients

Guidelines Updated to Encourage Genetic Testing

Nov 27, 2018

The American Society of Clinical Oncology (ASCO) and the National Comprehensive Cancer Network (NCCN) provide the healthcare community with current […]
READ MORE

Clinical Guidelines for Metastatic Disease Updated

May 24, 2018

The American Society of Clinical Oncology (ASCO) has updated their treatment guidelines for patients with metastatic pancreatic cancer, or disease […]
READ MORE

New Treatment Guidelines to Improve Patient Options

May 2, 2018

Editor’s note: Below we describe recent updates to the National Comprehensive Cancer Network’s (NCCN) guidelines for the treatment and management […]
READ MORE

Survey Highlights the Importance of Seeing Specialists

Nov 29, 2017

Published in the Journal of Gastrointestinal Cancer, a recent survey of 150 oncologists showed a lack of compliance with evidence-based […]
READ MORE

Pancreatic Cancer Action Network®, PanCAN®, PurpleStride®, Wage Hope®, Know Your Tumor®, Powerful Knowledge. Personal Treatment.®, Precision Promise℠ and Demand Better For Patients. For Survival.℠ are the trademarks of the Pancreatic Cancer Action Network, Inc.

The Pancreatic Cancer Action Network is registered as a 501©3 nonprofit organization. Contributions to the Pancreatic Cancer Action Network are tax-deductible to the extent permitted by law. The Pancreatic Cancer Action Network’s tax identification number is #33-0841281.